The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction

Canadian Journal of Cardiology

Volumn 24, Issue 5, 2008, Pages 375-378

  Cakmak, Mahmut ^a,c   Cakmak, Nazmiye ^a   Cetemen, Sebnem ^a   Tanriverdi, Halil ^b   Enc, Yavuz ^a   Teskin, Onder ^a   Kilic, I Dogu ^b  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Acute myocardial infarction; Diabetes; HbA1c; Ischemic score; Prognosis

Indexed keywords

FIBRINOLYTIC AGENT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; BLOOD; HEART INFARCTION; MIDDLE AGED;

AGED; BLOOD GLUCOSE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 44949176122     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70600-7     Document Type: Article

References (24)

1. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL; ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002;40:1748-54.
2. Tenerz A, Norhammar A, Silveira A, et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003;26:2770-6.
3. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626-32.
4. Fujiwara K, Hiasa Y, Takahashi T, et al. Influence of diabetes mellitus on outcome in the era of primary stenting for acute myocardial infarction. Circ J 2002:66;800-4.
5. Timmer JR, Ottervanger JP, de Boer MJ, et al; Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005;45:999-1002.
6. Husband DJ, Alberti KG, Julian DG. "Stress" hyperglycaemia during acute myocardial infarction: An indicator of pre-existing diabetes? Lancet 1983;2:179-81.
7. Oswald GA, Yudkin JS. Hyperglycaemia following acute myocardial infarction: The contribution of undiagnosed diab. Diabet Med 1987;4:68-70.
8. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies. Ann Intern Med 1996;124:127-30.
9. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001;322:15-8.
10. Kaul S, Finkelstein DM, Homma S, Leavitt M, Okada RD, Boucher CA. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: A comparison with cardiac catheterization. J Am Coll Cardiol 1988;12:25-34.
11. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
12. Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004;21:305-10.
13. Timmer JR, van der Horst IC, Ottervanger JP, et al; Zwolle Myocardial Infarction Study Group. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004;148:399-404.
14. Mizock BA. Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001;15:533-51.
15. Gosselink AT, Liem AL, Reiffers S, Zijlstra F. Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty. The Zwolle Myocardial Infarction Study Group. Clin Cardiol 1998;21:254-60.
16. DeGeare VS, Boura JA, Grines LL, O'Neill WW, Grines CL. Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2001;87:1035-8.
17. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care 1998;21:246-9.
18. Li D, Zhao L, Liu M, et al. Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J 1999;137:1145-52.
19. Ferrari R. The role of TNF in cardiovascular disease. Pharmacol Res 1999;40:97-105.
20. Fujita H, Morita I, Murota S. A possible involvement of ion transporter in tumor necrosis factor alpha and cycloheximide-induced apoptosis of endothelial cells. Mediators Inflamm 1999;8:211-8.
21. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000;355:773-8.
22. Li YP, Reid MB. Effect of tumor necrosis factor-alpha on skeletal muscle metabolism. Curr Opin Rheumatol 2001;13:483-7.
23. Eschwege E, Richard JL, Thibult N, et al. [Diabetes, hyperglycemia, hyperinsulinemia and risk of cardiovascular mortality. Findings of the Paris Prospective Survey, 10 years later.J Rev Epidemiol Sante Publique 1985;33:352-7.
24. Kosuge M, Kimura K, Kojima S, et al; Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 2005:69;375-9.